Oppenheimer Downgrades Northwest Biotherapeutics (NWBO) to Perform
Tweet
Share
E-mailGet Alerts NWBO Hot Sheet
Price: $0.19 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Oppenheimer downgraded Northwest Biotherapeutics (NASDAQ: NWBO) from Outperform to Perform and removed its price target (prior $5.00).
For an analyst ratings summary and ratings history on Northwest Biotherapeutics click here. For more ratings news on Northwest Biotherapeutics click here.
Shares of Northwest Biotherapeutics closed at $9.18 yesterday.
For an analyst ratings summary and ratings history on Northwest Biotherapeutics click here. For more ratings news on Northwest Biotherapeutics click here.
Shares of Northwest Biotherapeutics closed at $9.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- UBS Downgrades DiaSorin SpA (DIA:IM) (DSRLF) to Sell
- China Renaissance Downgrades Tencent Music Entertainment Group (TME) to Hold
Create E-mail Alert Related Categories
Downgrades, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
